DK0495825T3 - Anvendelse af antigestagener til fremstilling af lægemidler - Google Patents

Anvendelse af antigestagener til fremstilling af lægemidler

Info

Publication number
DK0495825T3
DK0495825T3 DK90914901.5T DK90914901T DK0495825T3 DK 0495825 T3 DK0495825 T3 DK 0495825T3 DK 90914901 T DK90914901 T DK 90914901T DK 0495825 T3 DK0495825 T3 DK 0495825T3
Authority
DK
Denmark
Prior art keywords
antigestagens
manufacture
drugs
medicaments
regarded
Prior art date
Application number
DK90914901.5T
Other languages
English (en)
Inventor
Horst Michna
Martin Schneider
Etreby M Fathy El
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of DK0495825T3 publication Critical patent/DK0495825T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK90914901.5T 1989-10-11 1990-10-11 Anvendelse af antigestagener til fremstilling af lægemidler DK0495825T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3934405A DE3934405A1 (de) 1989-10-11 1989-10-11 Verwendung von antigestagenen zur herstellung von arzneimitteln

Publications (1)

Publication Number Publication Date
DK0495825T3 true DK0495825T3 (da) 1996-07-22

Family

ID=6391518

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90914901.5T DK0495825T3 (da) 1989-10-11 1990-10-11 Anvendelse af antigestagener til fremstilling af lægemidler

Country Status (10)

Country Link
EP (1) EP0495825B1 (da)
JP (1) JPH05500947A (da)
AT (1) ATE135219T1 (da)
AU (1) AU648046B2 (da)
CA (1) CA2067173A1 (da)
DE (2) DE3934405A1 (da)
DK (1) DK0495825T3 (da)
ES (1) ES2086413T3 (da)
GR (1) GR3019824T3 (da)
WO (1) WO1991005557A1 (da)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0310542B1 (de) * 1987-10-01 1994-06-08 Schering Aktiengesellschaft Antigestagen- und antiöstrogenwirksame Verbindungen zur Behandlung hormonabhängiger Tumoren

Also Published As

Publication number Publication date
EP0495825A1 (de) 1992-07-29
DE3934405A1 (de) 1991-04-18
ES2086413T3 (es) 1996-07-01
JPH05500947A (ja) 1993-02-25
AU648046B2 (en) 1994-04-14
ATE135219T1 (de) 1996-03-15
WO1991005557A1 (de) 1991-05-02
EP0495825B1 (de) 1996-03-13
AU6524590A (en) 1991-05-16
CA2067173A1 (en) 1991-04-12
GR3019824T3 (en) 1996-08-31
DE59010204D1 (de) 1996-04-18

Similar Documents

Publication Publication Date Title
ES2147720T3 (es) Factor de celulas madre.
ES2058151T3 (es) Complejos de saponinas con fosfolipidos y composiciones farmaceuticas y cosmeticas que los contienen.
GT197956109A (es) Pyri dinyl-2(ih)-pyridinones y su preparacion
IT8322630A0 (it) Preparato di medicamento per migliorare i sintomi del cancro.
FI963049A0 (fi) Progesteroniantagonisteja lääkeaineiden valmistamiseksi, jotka on tarkoitettu kohdun toimintahäiriöistä johtuvien verenvuotojen hoitamiseksi
IT1205849B (it) Derivati di indolo,procedimenti per prepararli e composizioni farmaceutiche che li contengono per il trattamento di emicrania
DE60027768D1 (de) Behandlung von metastatischer krankheit
JPS5227238A (en) Re power synthesizer and distributor
DK0495825T3 (da) Anvendelse af antigestagener til fremstilling af lægemidler
DE69128254D1 (de) Antihypertensive benzopyran-derivate
ATE334683T1 (de) Verwendung von 11beta-(4-acetylphenyl)-17beta-
ECSP034606A (es) Uso de antiprogestinas para la induccion de apoptosis en una celula
JPS5411682A (en) Semiconductor device
JPS5259174A (en) Preparation of n-substituted uracil compounds
JPS5249767A (en) Semiconductor device
Mizuno Differences of gastric cancers between the greater and the lesser curvature Part III. On the differences of the ribose nucleic acid content of the cancer cells between the greater and the lesser curvatures
JPS5397343A (en) Semiconductor memory cell
JPS53104138A (en) Minicomputer composite system
JPS51123074A (en) Production process of fet
SU535106A1 (ru) Магнитогидростатический сепаратор
SHIMURA et al. Studies on Spotaneous Healing of Malignant Tumor (First Report) Significance of RES Affecting to the Growth of Transplanted Sarcoma in Rats
ECSP972072A (es) Nuevos pirimido [1,2-a] indoles
JPS51150935A (en) Semiconductor unit
JPS51128987A (en) Process for preparing alkoxypyrimidines
JPS5347540A (en) Cosmetic base composition